{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:58:18Z","timestamp":1781607498007,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005721","name":"Universit\u00e4t Bielefeld","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>ADHD is associated with several health outcomes, but its long-term cerebrovascular associations, particularly in adults with metabolic conditions, remain poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort analysis was performed using the Disease Analyzer database (IQVIA) and included adults with ADHD which were compared to a propensity score matched non-ADHD cohort. The 10-year incidence of acute ischemic stroke (AIS) or transient ischemic attack (TIA) was analyzed using Kaplan-Meier curves and univariable conditional Cox regression models with hazard ratios (HRs) and 99% confidence intervals (CIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 8,943 ADHD patients and 44,660 controls, 1.7% of ADHD patients and 1.2% of controls experienced AIS or TIA (log-rank test, p = 0.006). In the regression analysis, there was a significant association between ADHD and subsequent TIA or AIS in the total population (HR: 1.69; 99% CI:1.13-2.51). This association was stronger and significant in subgroups of patients aged &gt;45 years (HR: 2.34; 99% CI: 1.43-3.81) and those with obesity (HR: 1.86; 99% CI: 1.22-2.83), hypertension (HR: 2.18; 99% CI: 1.19-3.97), or dyslipidemia (HR: 2.89; 99% CI: 1.48-5.52).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ADHD in adults, particularly those over 45 years of age and those with metabolic comorbidities, is associated with an increased risk of cerebrovascular disease. Further research is needed to confirm these associations and to explore the underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-025-07246-9","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T09:24:04Z","timestamp":1755681844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cerebrovascular diseases in ADHD patients with metabolic comorbidities: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Sarah","family":"Krieg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Krieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Kostev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"7246_CR1","doi-asserted-by":"publisher","first-page":"15020","DOI":"10.1038\/nrdp.2015.20","volume":"1","author":"SV Faraone","year":"2015","unstructured":"Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, Rohde LA, Sonuga-Barke EJ, Tannock R, Franke B. Attention-deficit\/hyperactivity disorder. Nat Reviews Disease Primers. 2015;1:15020.","journal-title":"Nat Reviews Disease Primers"},{"issue":"3","key":"7246_CR2","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1192\/bjp.bp.107.048827","volume":"194","author":"V Simon","year":"2009","unstructured":"Simon V, Czobor P, B\u00e1lint S, M\u00e9sz\u00e1ros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry: J Mental Sci. 2009;194(3):204\u201311.","journal-title":"Br J Psychiatry: J Mental Sci"},{"issue":"9","key":"7246_CR3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.biopsych.2005.09.011","volume":"59","author":"J Biederman","year":"2006","unstructured":"Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit\/hyperactivity disorder. Biol Psychiatry. 2006;59(9):829\u201335.","journal-title":"Biol Psychiatry"},{"issue":"6","key":"7246_CR4","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.euroneuro.2012.06.011","volume":"23","author":"E Mick","year":"2013","unstructured":"Mick E, McManus DD, Goldberg RJ. Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adults. Eur Neuropsychopharmacology: J Eur Coll Neuropsychopharmacol. 2013;23(6):534\u201341.","journal-title":"Eur Neuropsychopharmacology: J Eur Coll Neuropsychopharmacol"},{"key":"7246_CR5","volume":"353","author":"JY Shin","year":"2016","unstructured":"Shin JY, Roughead EE, Park BJ, Pratt NL. Cardiovascular safety of methylphenidate among children and young people with attention-deficit\/hyperactivity disorder (ADHD): nationwide self controlled case series study. BMJ (Clinical Res ed). 2016;353: i2550.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"10","key":"7246_CR6","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/mp.2011.138","volume":"17","author":"B Franke","year":"2012","unstructured":"Franke B, Faraone SV, Asherson P, Buitelaar J, Bau CH, Ramos-Quiroga JA, Mick E, Grevet EH, Johansson S, Haavik J, et al. The genetics of attention deficit\/hyperactivity disorder in adults, a review. Mol Psychiatry. 2012;17(10):960\u201387.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"7246_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4088\/JCP.v66n0215","volume":"66","author":"TE Wilens","year":"2005","unstructured":"Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, Scott M, Podolski A, Ditterline JW, Morris MC, et al. Blood pressure changes associated with medication treatment of adults with attention-deficit\/hyperactivity disorder. J Clin Psychiatry. 2005;66(2):253\u20139.","journal-title":"J Clin Psychiatry"},{"issue":"20","key":"7246_CR8","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1056\/NEJMoa1110212","volume":"365","author":"WO Cooper","year":"2011","unstructured":"Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, et al. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med. 2011;365(20):1896\u2013904.","journal-title":"N Engl J Med"},{"issue":"10","key":"7246_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"Global","year":"2021","unstructured":"Global. regional, and National burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol. 2021;20(10):795\u2013820.","journal-title":"Lancet Neurol"},{"issue":"8","key":"7246_CR10","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254-743.","journal-title":"Circulation"},{"issue":"10046","key":"7246_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","volume":"388","author":"MJ O\u2019Donnell","year":"2016","unstructured":"O\u2019Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet (London England). 2016;388(10046):761\u201375.","journal-title":"Lancet (London England)"},{"issue":"1","key":"7246_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/14779072.2023.2160319","volume":"21","author":"SE Choi","year":"2023","unstructured":"Choi SE, Sagris D, Hill A, Lip GYH, Abdul-Rahim AH. Atrial fibrillation and stroke. Expert Rev Cardiovasc Ther. 2023;21(1):35\u201356.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1","key":"7246_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1161\/STROKEAHA.111.630871","volume":"43","author":"JY Dong","year":"2012","unstructured":"Dong JY, Zhang YH, Tong J, Qin LQ. Depression and risk of stroke: a meta-analysis of prospective studies. Stroke. 2012;43(1):32\u20137.","journal-title":"Stroke"},{"issue":"20","key":"7246_CR14","doi-asserted-by":"publisher","first-page":"e2715","DOI":"10.1212\/WNL.0000000000010982","volume":"95","author":"SAE Peters","year":"2020","unstructured":"Peters SAE, Carcel C, Millett ERC, Woodward M. Sex differences in the association between major risk factors and the risk of stroke in the UK biobank cohort study. Neurology. 2020;95(20):e2715\u201326.","journal-title":"Neurology"},{"issue":"24","key":"7246_CR15","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1001\/jama.2011.1830","volume":"306","author":"LA Habel","year":"2011","unstructured":"Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, Cheetham TC, Quinn VP, Dublin S, Boudreau DM, et al. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA. 2011;306(24):2673\u201383.","journal-title":"JAMA"},{"issue":"5","key":"7246_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.biopsych.2015.11.024","volume":"81","author":"JT Instanes","year":"2017","unstructured":"Instanes JT, Halm\u00f8y A, Engeland A, Haavik J, Furu K, Klungs\u00f8yr K. Attention-deficit\/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases. Biol Psychiatry. 2017;81(5):452\u20139.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"7246_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1001\/jamapsychiatry.2023.4294","volume":"81","author":"L Zhang","year":"2024","unstructured":"Zhang L, Li L, Andell P, Garcia-Argibay M, Quinn PD, D\u2019Onofrio BM, Brikell I, Kuja-Halkola R, Lichtenstein P, Johnell K, et al. Attention-deficit\/hyperactivity disorder medications and long-term risk of cardiovascular diseases. JAMA Psychiatr. 2024;81(2):178\u201387.","journal-title":"JAMA Psychiatr"},{"issue":"3","key":"7246_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40263-017-0410-7","volume":"31","author":"L Hennissen","year":"2017","unstructured":"Hennissen L, Bakker MJ, Banaschewski T, Carucci S, Coghill D, Danckaerts M, Dittmann RW, Hollis C, Kovshoff H, McCarthy S, et al. Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: a systematic review and meta-analysis of trials of methylphenidate, amphetamines and atomoxetine. CNS Drugs. 2017;31(3):199\u2013215.","journal-title":"CNS Drugs"},{"issue":"10","key":"7246_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5414\/CP203320","volume":"56","author":"W Rathmann","year":"2018","unstructured":"Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K. Basic characteristics and representativeness of the German disease analyzer database. Int J Clin Pharmacol Ther. 2018;56(10):459\u201366.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"11","key":"7246_CR20","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00592-022-01943-7","volume":"59","author":"W Rathmann","year":"2022","unstructured":"Rathmann W, Kostev K. Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database. Acta Diabetol. 2022;59(11):1443\u201351.","journal-title":"Acta Diabetol"},{"key":"7246_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11101499","author":"L Jacob","year":"2023","unstructured":"Jacob L, Smith L, Koyanagi A, Haro JM, Shin JI, Tanislav C, Schnitzler A, Kostev K. Chronic low back pain and incident transient ischemic attack and stroke in general practices in Germany. Healthcare. 2023. https:\/\/doi.org\/10.3390\/healthcare11101499.","journal-title":"Healthcare"},{"issue":"4","key":"7246_CR22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4088\/JCP.v67n0403","volume":"67","author":"J Biederman","year":"2006","unstructured":"Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67(4):524\u201340.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"7246_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/oby.2008.587","volume":"17","author":"SL Pagoto","year":"2009","unstructured":"Pagoto SL, Curtin C, Lemon SC, Bandini LG, Schneider KL, Bodenlos JS, Ma Y. Association between adult attention deficit\/hyperactivity disorder and obesity in the US population. Obesity. 2009;17(3):539\u201344.","journal-title":"Obesity"},{"issue":"9921","key":"7246_CR24","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","volume":"383","author":"SS Mahmood","year":"2014","unstructured":"Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet (London England). 2014;383(9921):999\u20131008.","journal-title":"Lancet (London England)"},{"key":"7246_CR25","doi-asserted-by":"publisher","unstructured":"Bundes\u00e4rztekammer (B\u00c4K). Kassen\u00e4rztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Hypertonie\u2013 Langfassung, Version 1.0. 2023 [cited: 2025-03-11]. https:\/\/doi.org\/10.6101\/AZQ\/000502. In.","DOI":"10.6101\/AZQ\/000502"},{"key":"7246_CR26","doi-asserted-by":"publisher","first-page":"1049211","DOI":"10.3389\/fendo.2022.1049211","volume":"13","author":"X Cai","year":"2022","unstructured":"Cai X, Hu J, Zhu Q, Wang M, Liu S, Dang Y, Hong J, Li N. Relationship of the metabolic score for insulin resistance and the risk of stroke in patients with hypertension: a cohort study. Front Endocrinol. 2022;13:1049211.","journal-title":"Front Endocrinol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07246-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-07246-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-07246-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:42:35Z","timestamp":1781606555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-025-07246-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7246"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-07246-9","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"16 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research adhered to the principles outlined in the Declaration of Helsinki. The analysis was performed using the \u201cDisease Analyzer\u201d database, which comprises anonymized electronic patient records. All patient data were analyzed in an aggregated format, ensuring that no individual data were accessible. In compliance with national and European regulations, obtaining individual consent was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"799"}}